Trial Information

Summary: A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.

Status: Completed

Protocol Number: NV20236

Sponsor: Hoffmann-La Roche

Company Division: Pharmaceutical

Official Scientific Title: An open-label multi-center trial of oseltamivir for the seasonal prophylaxis of influenza in children.

Brief Summary: This study will evaluate the safety of Tamiflu, when used for the prevention of influenza in children during the flu season. Children who would benefit from influenza prophylaxis when influenza is circulating in the community will receive treatment with Tamiflu syrup (or capsules) 30mg-75mg once daily (dependent on body weight) for 6 weeks. Safety data and influenza symptoms will be recorded throughout the study. The anticipated time on study treatment is <3 months, and the target sample size is <100 individuals. Target sample size is 50.

Study Phase: IV

Study Design / Study Details:

  • Purpose: Prevention
  • Allocation: Non-Randomized
  • Masking: Open Label
  • Control: Uncontrolled
  • Assignment: Single Group
  • Endpoints: Safety/Efficacy

Study Type:

Interventional

Condition: Influenza

Intervention Type: Drug

Intervention Name: oseltamivir [Tamiflu]

Primary Outcome: 1. AEs, laboratory parameters, vital signs. Time frame: Throughout study 2. Percentage of patients with laboratory confirmed clinical influenza Time frame: Throughout study

Key Secondary Outcomes: 1. Percentage of subjects with asymptomatic influenza; percentage with an influenza-like illness. Time frame: Throughout study

Inclusion Criteria:

  • males or females, 1-12 years of age;
  • candidate for seasonal prophylaxis;
  • negative rapid diagnostic test for influenza at baseline.

Exclusion Criteria:

  • symptoms suggestive of influenza-like illness;
  • positive rapid diagnostic test for influenza;
  • antiviral treatment for influenza in 2 weeks prior to randomization.

Gender: Males or Females

Age Limits: Min: 1 year Years Max: 12 Years

Accepts Healthy Volunteers: No

Trial Registration Date: 12/18/2006

Date Last Updated: 10/17/2008

Link To Trial Results

Contact:

Research Site:
Located In:
Pittsburgh, PA 15213
Telephone: 973-235-5000 or 800-526-6367

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: November 17, 2008 at 2:35:08 PM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA